Immix Biopharma Inc (IMMX)
Healthcare
Biotechnology
8.30 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Immix Biopharma Inc (IMMX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.0% of the shares are freely tradable; institutional investors hold 45.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
45.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
17.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
61.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
71Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HHG PLC | 6.75 | 4,802,002 | +22.5 | 03/31/2026 |
| Saturn V Capital Management LLC | 5.19 | 3,693,585 | +23.2 | 03/31/2026 |
| Eventide Asset Management, LLC | 3.58 | 2,549,019 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.51 | 1,787,994 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 2.46 | 1,750,200 | +5.4 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 2.31 | 1,641,552 | -17.0 | 03/31/2026 |
| Logos Global Management LP | 1.72 | 1,225,000 | +22.5 | 03/31/2026 |
| Vanguard Group Inc | 1.54 | 1,095,814 | +50.1 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 3.58 | 2,549,019 | +0.0 | 03/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 1.81 | 1,285,595 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.